Zobrazeno 1 - 10 of 787 pro vyhledávání: '"Esquivias, J"'
1
Akademický článek
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
Autor: Nuermberger EL; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Martínez-Martínez MS; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Sanz O; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Urones B; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Esquivias J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Soni H; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Tasneen R; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Tyagi S; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Li SY; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Converse PJ; Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins Universitygrid.21107.35grid.471401.7grid.21107.35 School of Medicine, Baltimore, Maryland, USA., Boshoff HI; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Robertson GT; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA., Besra GS; Institute of Microbiology and Infection, School of Biosciences, University of Birminghamgrid.6572.6, Birmingham, United Kingdom., Abrahams KA; Institute of Microbiology and Infection, School of Biosciences, University of Birminghamgrid.6572.6, Birmingham, United Kingdom., Upton AM; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA., Mdluli K; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA., Boyle GW; GSK: Research, GlaxoSmithKline R&D, Ware, United Kingdom., Turner S; GSK: Research, GlaxoSmithKline R&D, Ware, United Kingdom., Fotouhi N; TB Alliance: Global Alliance for Tuberculosis Drug Development, New York, New York, USA., Cammack NC; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Siles JM; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Alonso M; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Escribano J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Lelievre J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Rullas-Trincado J; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Pérez-Herrán E; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Bates RH; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Maher-Edwards G; GSK, Brentford, Middlesex, United Kingdom., Barros D; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Ballell L; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain., Jiménez E; Diseases of the Developing World, GlaxoSmithKline R+D Limited, Tres Cantos, Madrid, Spain.
Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 Jun 21; Vol. 66 (6), pp. e0013222. Date of Electronic Publication: 2022 May 24.
Zobrazit plný text záznamu
2
Akademický článek
Environmental fungi target thiol homeostasis to compete with Mycobacterium tuberculosis.
Autor: Malhotra, Neha1 (AUTHOR), Oh, Sangmi1 (AUTHOR), Finin, Peter1 (AUTHOR), Medrano, Jessica1 (AUTHOR), Andrews, Jenna1 (AUTHOR), Goodwin, Michael1 (AUTHOR), Markowitz, Tovah E.2 (AUTHOR), Lack, Justin2 (AUTHOR), Boshoff, Helena I. M.1 (AUTHOR), Barry III, Clifton Earl1 (AUTHOR) cbarry@niaid.nih.gov
Publikováno v: PLoS Biology. 12/3/2024, Vol. 22 Issue 12, p1-26. 26p.
Zobrazit plný text záznamu
3
Akademický článek
Lack of Specificity of Phenotypic Screens for Inhibitors of the Mycobacterium tuberculosis FAS-II System.
Autor: Grzegorzewicz AE; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland., Lelièvre J; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain., Esquivias J; Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain., Angala B; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA., Liu J; Department of Chemical Biology & Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Lee RE; Department of Chemical Biology & Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., McNeil MR; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA., Jackson M; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA mary.jackson@colostate.edu.
Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2020 Dec 16; Vol. 65 (1). Date of Electronic Publication: 2020 Dec 16 (Print Publication: 2020).
Zobrazit plný text záznamu
4
Akademický článek
Development of a novel secondary phenotypic screen to identify hits within the mycobacterial protein synthesis pipeline.
Autor: Burke C; Institute of Microbiology and Infection School of Biosciences University of Birmingham Birmingham UK., Jankute M; Institute of Microbiology and Infection School of Biosciences University of Birmingham Birmingham UK., Moynihan P; Institute of Microbiology and Infection School of Biosciences University of Birmingham Birmingham UK., Gonzalez Del Rio R; Diseases of the Developing World GlaxoSmithKline Tres Cantos Madrid Spain., Li X; Department of Biochemistry and Biophysics Texas A&M University College Station Texas United States., Esquivias J; Diseases of the Developing World GlaxoSmithKline Tres Cantos Madrid Spain., Lelièvre J; Diseases of the Developing World GlaxoSmithKline Tres Cantos Madrid Spain., Cox JAG; School of Life & Health Sciences Aston University Birmingham UK., Sacchettini J; Department of Biochemistry and Biophysics Texas A&M University College Station Texas United States., Besra GS; Institute of Microbiology and Infection School of Biosciences University of Birmingham Birmingham UK.
Publikováno v: FASEB bioAdvances [FASEB Bioadv] 2020 Aug 20; Vol. 2 (10), pp. 600-612. Date of Electronic Publication: 2020 Aug 20 (Print Publication: 2020).
Zobrazit plný text záznamu
5
Akademický článek
Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization around a Genotoxic Metabolite.
Autor: Cunningham F; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Esquivias J; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Fernández-Menéndez R; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Pérez A; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Guardia A; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Escribano J; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Rivero C; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Vimal M; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K., Cacho M; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., de Dios-Antón P; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Martínez-Martínez MS; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Jiménez E; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Huertas Valentín L; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Rebollo-López MJ; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., López-Román EM; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Sousa-Morcuende V; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Rullas J; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain., Neu M; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K., Chung CW; GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, U.K., Bates RH; Global Health R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, 28760 Madrid, Spain.
Publikováno v: ACS infectious diseases [ACS Infect Dis] 2020 May 08; Vol. 6 (5), pp. 1098-1109. Date of Electronic Publication: 2020 Mar 20.
Zobrazit plný text záznamu
6
Akademický článek
Plasmodium falciparum Mitochondrial Complex III, the Target of Atovaquone, Is Essential for Progression to the Transmissible Sexual Stages.
Autor: Sheokand, Pradeep Kumar1 (AUTHOR) pradeepsheokand6@gmail.com, Pradhan, Sabyasachi1 (AUTHOR), Maclean, Andrew E.1 (AUTHOR), Mühleip, Alexander1 (AUTHOR), Sheiner, Lilach1 (AUTHOR) lilach.sheiner@glasgow.ac.uk
Publikováno v: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9239. 18p.
Zobrazit plný text záznamu
8
Akademický článek
Easy-To-Synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity against Mycobacterium tuberculosis.
Autor: Guardia A; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Baiget J; School of Chemistry , The University of Sydney , Sydney , NSW 2006 , Australia., Cacho M; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Pérez A; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Ortega-Guerra M; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Nxumalo W; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Khanye SD; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Rullas J; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Ortega F; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Jiménez E; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Pérez-Herrán E; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Fraile-Gabaldón MT; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Esquivias J; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Fernández R; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Porras-De Francisco E; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Encinas L; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Alonso M; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Giordano I; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Rivero C; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Miguel-Siles J; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Osende JG; School of Chemistry , The University of Sydney , Sydney , NSW 2006 , Australia., Badiola KA; School of Chemistry , The University of Sydney , Sydney , NSW 2006 , Australia., Rutledge PJ; School of Chemistry , The University of Sydney , Sydney , NSW 2006 , Australia., Todd MH; School of Chemistry , The University of Sydney , Sydney , NSW 2006 , Australia.; School of Pharmacy , University College London , 29-39 Brunswick Square , London WC1N 1AX , U.K., Remuiñán M; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain., Alemparte C; GlaxoSmithKline , Tres Cantos Medicines Development Campus, Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2018 Dec 27; Vol. 61 (24), pp. 11327-11340. Date of Electronic Publication: 2018 Dec 12.
Zobrazit plný text záznamu
9
Akademický článek
High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
Autor: Hidalgo-Tenorio C; Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen de las Nieves, Granada, España. Electronic address: chidalgo72@gmail.com., de Jesus SE; Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen de las Nieves, Granada, España., Esquivias J; Servicio de Anatomía Patológica, Hospital Universitario Virgen de las Nieves, Granada, España., Pasquau J; Servicio de Enfermedades Infecciosas, Hospital Universitario Virgen de las Nieves, Granada, España.
Publikováno v: Enfermedades infecciosas y microbiologia clinica (English ed.) [Enferm Infecc Microbiol Clin (Engl Ed)] 2018 Nov; Vol. 36 (9), pp. 555-562. Date of Electronic Publication: 2017 Dec 06.
Zobrazit plný text záznamu
10
Akademický článek
Factors associated with human papillomavirus infections among women living with HIV in public health facilities in Western Oromia, Ethiopia.
Autor: Abdi, Mulatu1 (AUTHOR), Tamiru, Afework2 (AUTHOR), Tilahun, Temesgen3 (AUTHOR), Tiruneh, Gemechu2 (AUTHOR), Fite, Meseret Belete2,4 (AUTHOR) meseretphd2014@gmail.com
Publikováno v: BMC Women's Health. 7/25/2024, Vol. 24, p1-10. 10p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje